Vanda Repiská
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Genetics top 10%
- Mesenchymal stem cell research
Papers in ⓘ
-
- Extracellular vesicles in disease 8
- RNA modifications and cancer 5
-
- Cancer Genomics and Diagnostics 11
- MicroRNA in disease regulation 7
- Co-authors
- Č Altaner (8 shared papers)Ursula Altanerova (7 shared papers)Jana Jakubechova (6 shared papers)Gabriel Minárik (7 shared papers)Peter Stanko (1 shared paper)Helena Gbelcová (9 shared papers)Veronika Altanerová (2 shared papers)Peter Babinec (1 shared paper)
In The Last Decade
Vanda Repiská
64 papers receiving 892 citations
Peers
Comparison fields: 5 of 98
- Cancer Research 260
- Genetics 114
- Molecular Biology 488
- Pediatrics, Perinatology and Child Health 102
- Urology 32
Countries citing papers authored by Vanda Repiská
This map shows the geographic impact of Vanda Repiská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanda Repiská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanda Repiská more than expected).
Fields of papers citing papers by Vanda Repiská
This network shows the impact of papers produced by Vanda Repiská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanda Repiská. The network helps show where Vanda Repiská may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanda Repiská, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 113 | |
| 2 | 2017 | 95 | |
| 3 | 2018 | 81 | |
| 4 | 2018 | 73 | |
| 5 | 2016 | 51 | |
| 6 | 2016 | 39 | |
| 7 | 2013 | 32 | |
| 8 | 2016 | 32 | |
| 9 | 2015 | 29 | |
| 10 | 2017 | 28 | |
| 11 | 2023 | 27 | |
| 12 | 2011 | 26 | |
| 13 | 2021 | 24 | |
| 14 | 2020 | 24 | |
| 15 | 2023 | 15 | |
| 16 | 2021 | 14 | |
| 17 | 2009 | 14 | |
| 18 | 2017 | 12 | |
| 19 | 2023 | 11 | |
| 20 | 2011 | 11 |
About Vanda Repiská
Vanda Repiská is a scholar working on Molecular Biology, Cancer Research, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 73 papers that have together received 899 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Gestational Trophoblastic Disease Studies (10 papers), Prenatal Screening and Diagnostics (10 papers), Genetic factors in colorectal cancer (8 papers), Extracellular vesicles in disease (8 papers), MicroRNA in disease regulation (7 papers), Endometrial and Cervical Cancer Treatments (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (260 citations), Genetics (114 citations), Molecular Biology (488 citations), Pediatrics, Perinatology and Child Health (102 citations) and Urology (32 citations). Vanda Repiská has collaborated with scholars based in Slovakia, Singapore and Czechia. Frequent co-authors include Č Altaner, Ursula Altanerova, Jana Jakubechova, Gabriel Minárik, Peter Stanko, Helena Gbelcová, Veronika Altanerová, Peter Babinec, Melánia Babincová and Ľ Danihel. Their work appears in journals such as Physiological Research, Cancers, International Journal of Molecular Sciences, Molecules and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.